360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

double-blinded

Type: Keyphrase

Name: double-blinded

First reported Jun 10 2013 - Updated Jun 10 2013 - 1 reports

Australian Computer Society

11th australasian data mining conference (AUSDM 2013)

nd CFP: AusDM 2013 Industry Track, submission due 15 July*********************************************************************The 11th Australasian Data Mining Conference (AusDM 2013)Join us on LinkedIn: http://www.linkedin.com/groups/AusDM-4907891** ... [Published Eventseer.net - Jun 10 2013]

Entities: Data Mining, double-blinded, Australian Computer Society

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Ferring announces encouraging data from Phase III labour induction study

Ferring Pharmaceuticals Inc., a research-driven, specialty biopharmaceutical company, has announced data from EXPEDITE study, which demonstrated the use of a controlled release misoprostol vaginal insert significantly reduced time to vaginal delivery ... [Published Individual.com - Jun 05 2013]

Entities: Ferring AB, Misoprostol, Phase III

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Effects of Antihypertensive Drugs on Central Blood Pressure in Humans: A Preliminary Observation

BACKGROUNDCentral blood pressure (BP) is considered a better predictor of cardiovascular events than brachial BP. Modifications of central, beyond brachial BP, can be assessed by pressure amplification, a potential new cardiovascular risk factor. Comparison ... [Published American Journal of Hypertension - Jun 05 2013]

Entities: Antihypertensive Drug, Indapamide, Amplification, Placebo, Drugs

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

You can’t exercise if you’re sick ...

Everyone knows that protein and recovery products help rebuild muscles and replace nutrients. But what about immune health? Research shows that intense exercise temporarily weakens the immune system. Repeated workouts can create an "open window" in your ... [Published New Hope 360 - Jun 04 2013]

Entities: Upper Respiratory Tract Infection, Yeast, Marathon

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

3 Types of Research Studies

If you're trying to make sense of health and medical research, it helps to understand the differences between three basic types of studies.Basic science/laboratory studies: These are conducted in cells, tissue or animals, typically mice or rats. This ... [Published Berkeley Wellness - Jun 04 2013]

Entities: Omega-3 Fatty Acid, Clinical trials, double-blinded

First reported Jun 03 2013 - Updated Jun 03 2013 - 1 reports

DR. KATZ: Amazing medical story proves a closed mind can be harmful

A study just reported at the Heart Failure 2013 Congress in Lisbon, Portugal, indicates that co-enzyme Q10 (co-Q10) is effective in congestive heart failure, improving both function and survival. Over a span of decades, very few medications have been ... [Published New Haven Register - Jun 03 2013]

Entities: congestive heart failure, Internal Medicine, CoQ10

First reported May 31 2013 - Updated Jun 01 2013 - 1 reports

Michael Bloomberg

Mayor Bloomberg Says Medical Marijuana Is A Hoax

New York City Mayor Michael Bloomberg today declared that medical marijuana is “one of the great hoaxes of all times.”He made these comments on his weekly radio show in the context of the state legislature’s vote to decriminalize small amounts of pot. ... [Published Inquisitr - May 31 2013]

Entities: Michael Bloomberg, Medical Marijuana, Legalization, double-blinded

First reported May 31 2013 - Updated Jun 01 2013 - 2 reports

NYC Mayor Bloomberg: Medical marijuana ‘one of the great hoaxes of all time’

New York City Michael Bloomberg lashed out at the medical marijuana community during his weekly radio show on Friday.“Medical, my foot,” Bloomberg told WOR-AM host John Gambling. “There is no medical. This is one of the great hoaxes of all times. The ... [Published Raw Story - May 31 2013]

Entities: Medical Marijuana, Michael Bloomberg, Drugs, Diane Savino

First reported May 29 2013 - Updated May 29 2013 - 1 reports

You can’t exercise if you’re sick

Entities: Upper Respiratory Tract Infection, Biothera, double-blinded, Marathon

First reported May 29 2013 - Updated May 29 2013 - 1 reports

Effectiveness of antimicrobial curtains in infection control

e shown a correlation between a cleaner patient environment, lower infection rates and reduced risk of transmission. A double-blinded randomised controlled trial conducted in two intensive care units by the University of Iowa showed that privacy curtains ... [Published Cleanroom Technology - May 29 2013]

Entities: Infection, University of Iowa, Bioburden

First reported May 28 2013 - Updated May 28 2013 - 1 reports

Magic bullet can't compete with science

Few things breed empathy like personal experience. The lure of promised but unproven 'magic bullet' therapies has taken on a new dimension for me, courtesy of a recent bout with Achilles tendinopathy.An eager recreational runner, I make up with enthusiasm ... [Published Australian Doctor - May 28 2013]

Entities: autologous, musculoskeletal, Revascularisation, double-blinded, Rotator Cuff

First reported May 25 2013 - Updated May 25 2013 - 1 reports

Letters: 'My View' irresponsible

Publishing information in your paper that seeks to attribute the MMR vaccine to autism is grossly irresponsible and destructive. The link stated by Cindy Pokezwinski in this piece is not based in scientific fact ("MMR vaccine caused my son's autism," ... [Published Deseret Morning News - May 25 2013]

Entities: Autism, MMR Vaccine, treatments, double-blinded, Publishing

Quotes

...analgesia in the validated pain models from our Phase 1 studies," said Robert Medve MD, SVP and Chief Medical Officer of Nektar Therapeutics. "These data suggest that NKTR-181 could change the way we think about opioids and how we treat patients with chronic pain."

Nektar Issues Data from Human Abuse Liability Study for NKTR-181 [Published Benzinga.com - 7 hours ago]

If patients have "run out of all sorts of options, randomizing them to imatinib instead of placebo certainly slows down the rate of progression, even in the absence of a response, and certainly can [have an] impact on their overall quality of life and their natural history" he said

Imatinib rechallenge improves PFS in GIST, but not for long [Published Oncology Report - Jun 18 2013]

"Canada is yet another significant possible market for AMR-001. With a strong patent portfolio already under our belts, we look forward to further expansion of our intellectual property in the coming years" said Dr. Robin L Smith, Chairman and CEO of NeoStem. NeoStem Inc. ("NeoStem" or the "Company") is a leader in the emerging cellular therapy industry...

NeoStem Announces Geographic Expansion of Intellectual Property Coverage of AMR-001 to Canada [Published Street Insider - Jun 17 2013]

According to the news editors, the research concluded: "These encouraging results justify a longer-term study to determine whether topically applied 0.5% retinal can provide benefits comparable with those seen with topically applied 1% retinol."

Researchers from Scripps Memorial Hospital Describe Findings in Dermatology [Published NewsRX - Jun 14 2013]

More Content

sort by: Date \| Relevance
Wednesday's Small Cap Biotech Catalyst Watch An... [Published Seeking Alpha - 6 hours ago]
Nektar Issues Data from Human Abuse Liability S... [Published Benzinga.com - 7 hours ago]
Imatinib rechallenge improves PFS in GIST, but ... [Published Oncology Report - Jun 18 2013]
Guided Method May Make Children Less Agitated A... [Published Digital Journal - Jun 18 2013]
Boston Scientific Begins Patient Enrollment In ... [Published PR Newswire: Health - Jun 17 2013]
NeoStem Announces Geographic Expansion of Intel... [Published Street Insider - Jun 17 2013]
Volcano Shares Results for its iFR Technology F... [Published Diagnostic & Invasive Cardiology - Jun 14 2013]
Researchers from Scripps Memorial Hospital Desc... [Published NewsRX - Jun 14 2013]
Olaparib in Patients With BRCA Mutated Platinum... [Published NewsRX - Jun 14 2013]
Jasarevic: Advice to protect your skin from the... [Published Kelowna Capital - Jun 13 2013]
Sanuwave: DermaPACE Could Be Very Competitive I... [Published Seeking Alpha - Jun 12 2013]
Ritter Pharmaceuticals' Study Shows That Alteri... [Published Market Wire - Jun 12 2013]
Thymoglobulin and Its Use in Renal Transplantat... [Published Sexual Development - Jun 11 2013]
Glaxo Reports Disappointing Tykerb Data Zacks [Published Yahoo! Finance - Jun 10 2013]
11th australasian data mining conference (AUSDM... [Published Eventseer.net - Jun 10 2013]
Exelixis Presents Cometriq Clinical Trial Data [Published Individual.com - Jun 06 2013]
Ferring announces encouraging data from Phase I... [Published Individual.com - Jun 05 2013]
Effects of Antihypertensive Drugs on Central Bl... [Published American Journal of Hypertension - Jun 05 2013]
You can’t exercise if you’re sick ... [Published New Hope 360 - Jun 04 2013]
Rockwell Medical announces encouraging results ... [Published Individual.com - Jun 04 2013]
A Placebo-Controlled, Randomized Trial of Mesen... [Published CHEST - Jun 04 2013]
Bayer announces positive data from Phase III PA... [Published Individual.com - Jun 04 2013]
3 Types of Research Studies [Published Berkeley Wellness - Jun 04 2013]
AstraZeneca Presents Olaparib Data Zacks [Published Yahoo! Finance - Jun 03 2013]
Single-Blind Trial: Diabetes Drug Helps Parkins... [Published Alzheimer Research Forum - Jun 03 2013]
New Clinical Trials and Studies Findings Has Be... [Published Pharmacy Choice - Jun 03 2013]
DR. KATZ: Amazing medical story proves a closed... [Published New Haven Register - Jun 03 2013]
Exelixis Presents COMETRIQ™ (cabozantinib) Clin... [Published Yahoo! Finance - Jun 02 2013]
Exelixis Presents COMETRIQ™ (cabozantinib) Clin... [Published Stockwatch - Jun 02 2013]
Olaparib in Patients With BRCA Mutated Platinum... [Published Enhanced Online News - Jun 01 2013]

Blogs

sort by: Date \| Relevance
NYC Mayor Bloomberg: Medical marijuana ‘one of ... [Published Raw Story - May 31 2013] New York City Michael Bloomberg lashed out at the medical marijuana community during his weekly radio show on Friday.“Medical, my foot,” Bloomberg told WOR-AM host John Gambling. “There is no medical. This is one of the great hoaxes of all times. The ...
Bloomberg Calls Medical Marijuana "One Of The G... [Published Gothamist - May 31 2013] Mayor Bloomberg has always been somewhat consistent in his views on marijuana: he used to love smoking it, but he regrets telling people that, because he's vehemently against legalization, because the new stuff is just too strong. See, simple! But now ...
Podcast interview with Cancer Treatment Centers... [Published Health Business Blog - May 10 2013] This is the transcript of my recent interview with Cancer Treatment Centers of America CEO Steve Bonner. David Williams : This is David E. Williams from the Health Business Group . I’m speaking today with Steve Bonner, CEO of Cancer Treatment Centers ...
Controversial No More – Study Shows Much Hyped ... [Published Singularity Hub - Apr 01 2013] [Source: Wikipedia] Paolo Zamboni didn’t buy into the conventional wisdom that multiple sclerosis was an autoimmune disorder resulting in the wearing away of the nervous system’s cellular insulation: myelin . Instead, the vascular surgeon from Italy ...
Thinking about the placebo effect as a “meaning... [Published blogs.worldbank.org - Feb 13 2013] In recent conversations on research, I’ve noticed that we often get confused when discussing the placebo effect. The mere fact of positive change in a control group administered a placebo does not imply a placebo effect – the change could be due to simple ...

Press Releases

sort by: Date \| Relevance
Boston Scientific Begins Patient Enrollment In ... [Published PR Newswire: Health - Jun 17 2013]
Olaparib in Patients With BRCA Mutated Platinum... [Published Business Wire Health News - Jun 01 2013]
Oculus Innovative Sciences Announces Completion... [Published GlobeNewswire: Advertising News - Mar 14 2013]
GlycoMimetics Completes Enrollment in Phase 2 S... [Published EON Health & Medicine - Jan 17 2013]
GlycoMimetics Completes Enrollment in Phase 2 S... [Published Business Wire Science: Science News - Jan 17 2013]